BindingDB logo
myBDB logout

BDBM264187 (2R)-2-[(2S)-2,4- dimethylpiperazin-1- yl]-N-(3-{2-[(3-ethoxy- 1-methyl-1H-pyrazol- 4-yl)amino]-5- fluoropyrimidin-4-yl}- 1H-indol-7-yl)propanamide::US9714236, 10a

SMILES: CCOc1nn(C)cc1Nc1ncc(F)c(n1)-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)C[C@@H]3C)cccc12

InChI Key: InChIKey=KUIUFOLGSATLQM-DLBZAZTESA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 264187   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
JAK1 (866-1154)


(Homo sapiens (human))
BDBM264187
PNG
((2R)-2-[(2S)-2,4- dimethylpiperazin-1- yl]-N-(3-{2...)
Show SMILES CCOc1nn(C)cc1Nc1ncc(F)c(n1)-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)C[C@@H]3C)cccc12
Show InChI InChI=1S/C27H34FN9O2/c1-6-39-26-22(15-36(5)34-26)32-27-30-13-20(28)23(33-27)19-12-29-24-18(19)8-7-9-21(24)31-25(38)17(3)37-11-10-35(4)14-16(37)2/h7-9,12-13,15-17,29H,6,10-11,14H2,1-5H3,(H,31,38)(H,30,32,33)/t16-,17+/m0/s1
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a 846n/an/an/an/a7.3n/a



ASTRAZENECA AB

US Patent


Assay Description
Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, #PV4774, Carlsbad, Calif.), JAK2 (amino aci...


US Patent US9714236 (2017)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3 (781-1124)


(Homo sapiens (human))
BDBM264187
PNG
((2R)-2-[(2S)-2,4- dimethylpiperazin-1- yl]-N-(3-{2...)
Show SMILES CCOc1nn(C)cc1Nc1ncc(F)c(n1)-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)C[C@@H]3C)cccc12
Show InChI InChI=1S/C27H34FN9O2/c1-6-39-26-22(15-36(5)34-26)32-27-30-13-20(28)23(33-27)19-12-29-24-18(19)8-7-9-21(24)31-25(38)17(3)37-11-10-35(4)14-16(37)2/h7-9,12-13,15-17,29H,6,10-11,14H2,1-5H3,(H,31,38)(H,30,32,33)/t16-,17+/m0/s1
PDB

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a>3.00E+4n/an/an/an/a7.3n/a



ASTRAZENECA AB

US Patent


Assay Description
Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, #PV4774, Carlsbad, Calif.), JAK2 (amino aci...


US Patent US9714236 (2017)

More data for this
Ligand-Target Pair
JAK2 (831-1132)


(Homo sapiens (human))
BDBM264187
PNG
((2R)-2-[(2S)-2,4- dimethylpiperazin-1- yl]-N-(3-{2...)
Show SMILES CCOc1nn(C)cc1Nc1ncc(F)c(n1)-c1c[nH]c2c(NC(=O)[C@@H](C)N3CCN(C)C[C@@H]3C)cccc12
Show InChI InChI=1S/C27H34FN9O2/c1-6-39-26-22(15-36(5)34-26)32-27-30-13-20(28)23(33-27)19-12-29-24-18(19)8-7-9-21(24)31-25(38)17(3)37-11-10-35(4)14-16(37)2/h7-9,12-13,15-17,29H,6,10-11,14H2,1-5H3,(H,31,38)(H,30,32,33)/t16-,17+/m0/s1
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
n/an/a>3.00E+4n/an/an/an/a7.3n/a



ASTRAZENECA AB

US Patent


Assay Description
Enzyme inhibition studies were performed using recombinant JAK1 (amino acids 866-1154, Life Technologies, #PV4774, Carlsbad, Calif.), JAK2 (amino aci...


US Patent US9714236 (2017)

More data for this
Ligand-Target Pair